Activ’Inside, an SME focusing on active ingredients obtained from plants, mainly vines and saffron, has stood out on the health ingredients market. Its recent consumer study has shown the effectiveness of Safr’Inside™, a patented saffron extract, on stress regulation. The findings also indicated improvement in mood in healthy people experiencing temporary or chronic stress. Therefore, the product is positioned as a natural solution for intense emotions, irritability, and mood disorders, among other uses.
The COVID-19 pandemic and measures introduced to curb it, such as lockdown and social distancing, affected morale and mental health. In this regard, stress, anxiety, and sadness have multiplied during this period. These aspects motivated Activ’Inside to determine how effective its patented saffron extract, Safr’Inside™ is on people without chronic depression facing prolonged stress.
The company conducted a consumer study under medical supervision with the research and survey institute Expansion Consulteam on 100 participants. The research comprised men and women aged between 30 and 50 years old in good health without psychological disorders or pathologies. The subjects were given two 15 mg doses of Safr’Inside™ daily for 30 days.
The effectiveness of the product and participants’ satisfaction was assessed through three questionnaires. After seven days of supplementation, Safr’Inside™ significantly reduced stress levels and improved daily mood. More than 80% of the participants found the product fast-acting, with benefits noticeable in less than five days. The initial results were also sustained after 30 days. Almost 80% of the subjects agreed that they wanted to continue taking the supplement.
Compared to other stress solutions, 60% of participants found Safr’Inside™ more effective, while 85% thought the supplement acted rapidly. At the end of the study, over 80% of participants said they were satisfied by Safr’Inside™ and would recommend it to a friend.
The beneficial effects of the product were confirmed by the supervising doctor, Dr. Sophie Leguen, a phytotherapy specialist, who stated, “I was surprised by Safr’Inside™ effect in monotherapy. A real difference could be observed. Even without having seen the statistical results, I am certain that the majority of patients have improved.”
The doctor established that between the start and the end of the course treatment, based on a validated questionnaire, daily stress dropped by 32%. Nervousness and stress were reduced by 60%, while irritability decreased by 46%. “I deeply felt that most of the participants had significant levels of daily stress before the study. They had a stress level between 7 and 9 on the stress scale. After the study, I felt that they were more between 3 and 5 on the same scale. Some of them even asked me where they could buy Safr’Inside. Others said that Safr’Inside™ was very effective,” she added.
“The results of our consumer study demonstrate the ability of Safr’Inside™ to satisfy a major public health challenge which today affects a large part of the population. These results are all the more important because, although several clinical studies have proven the beneficial effects of saffron on mood disorders in patients suffering from depression, few have looked into its effects on healthy people subject to stress situations: the potential consumers of food supplements. At a time when the health crisis has led to increased exposure to factors causing anxiety and depression, Safr’Inside™ appears a promising solution to lift the mood of people in good health and improve their daily lives when faced with omnipresent stress”, explained Benoit Lemaire, CEO of Activ’Inside.
